Autoantibody-mediated pain in long COVID: evidence from multiple lines - Takeaways - MDSpire

Autoantibody-mediated pain in long COVID: evidence from multiple lines

  • By

  • Charles Nicaise

  • Pierre Bulpa

  • Marc Jamoulle

  • June 17, 2026

  • 0 min

Share

  • 1

    Long COVID is a multifactorial condition with persistent symptoms, including fatigue, dyspnea, cognitive impairment, and chronic pain.

  • 2

    Women are disproportionately affected by long COVID, showing more multisystem and pain-related symptoms due to potential biological differences.

  • 3

    Research suggests that some long COVID symptoms may arise from autoimmune mechanisms mediated by pathogenic autoantibodies.

  • 4

    Studies indicate that patient-derived IgG can trigger pain-related phenotypes in animal models, supporting the role of autoimmunity.

  • 5

    The development of biomarkers for autoimmune-mediated pain endotypes is crucial for personalizing therapeutic interventions in long COVID.

Original Source(s)

Related Content